Telomere Therapeutics

About:

Telomere Therapeutics is a University of Barcelona spinoff developing telomerase gene therapy to treat pulmonary fibrosis

Website: https://telomere-tx.com/

Top Investors: Invivo Capital Partners, CDTI

Description:

Telomere Therapeutics creates gene therapy based on telomerase gene expression for the treatment of age-related diseases like idiopathic pulmonary fibrosis, aplastic anemia, or dyskeratosis congenita.

Total Funding Amount:

3.39M EUR

Headquarters Location:

Barcelona, Catalonia, Spain

Founded Date:

2020-11-01

Founders:

Fàtima Bosch, Maria Blasco, Paula Martínez

Number of Employees:

1-10

Last Funding Date:

2021-05-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai